BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15081273)

  • 1. Morphometric characterization of the neuromuscular junction of rodents intoxicated with 2,4-dithiobiuret: evidence that nerve terminal recycling processes contribute to muscle weakness.
    Rheuben MB; Autio DM; Xu YF; Atchison WD
    Toxicol Appl Pharmacol; 2004 Apr; 196(2):266-86. PubMed ID: 15081273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of synaptic vesicle exocytosis and recycling during neuromuscular weakness produced in mice by 2,4-dithiobiuret.
    Xu YF; Autio D; Rheuben MB; Atchison WD
    J Neurophysiol; 2002 Dec; 88(6):3243-58. PubMed ID: 12466444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of spontaneous and evoked release of acetylcholine during dithiobiuret-induced neuromuscular weakness.
    Atchison WD
    J Pharmacol Exp Ther; 1989 Jun; 249(3):735-43. PubMed ID: 2499675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the paralytic agent 2,4-dithiobiuret on viability and morphology of rat pheochromocytoma (PC12) cells.
    Rheuben MB; Autio DM; Yao AZ; Atchison WD
    Neurotoxicology; 1997; 18(1):105-22. PubMed ID: 9215993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose refractoriness to the neuromuscular toxicity of dithiobiuret in rats.
    Williams KD; Peterson RE; Atchison WD
    Neurotoxicology; 1992; 13(2):331-45. PubMed ID: 1436753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 2,4-dithiobiuret treatment in rats on cholinergic function and metabolism of the extensor digitorum longus muscle.
    Weiler MH; Williams KD; Peterson RE
    Toxicol Appl Pharmacol; 1986 Jun; 84(2):220-31. PubMed ID: 3087022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of 2,4-dithiobiuret on the synthesis and release of acetylcholine and dopamine from rat pheochromocytoma (PC12) cells.
    Ireland LM; Yan CH; Nelson LM; Atchison WD
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1453-62. PubMed ID: 8531116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The paralytic agent 2,4-dithiobiuret decreases open time of murine skeletal muscle acetylcholine receptor channels.
    Spitsbergen JM; Atchison WD
    J Pharmacol Exp Ther; 1995 Feb; 272(2):645-51. PubMed ID: 7531763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage clamp analysis reveals multiple populations of quanta released at neuromuscular junctions of rats treated with 2,4-dithiobiuret.
    Spitsbergen JM; Atchison WD
    J Pharmacol Exp Ther; 1991 Jan; 256(1):159-63. PubMed ID: 1899115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced safety factor for neuromuscular transmission and abnormal quantal secretion precede neuromuscular weakness induced by dithiobiuret.
    Atchison WD
    Toxicol Appl Pharmacol; 1990 Nov; 106(2):234-44. PubMed ID: 2175053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of dithiobiuret toxicity in rats.
    Williams KD; Lopachin RM; Atchison WD; Peterson RE
    Neurotoxicology; 1986; 7(1):33-49. PubMed ID: 3012425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal Schwann cell structure is altered in diaphragm of mdx mice.
    Personius KE; Sawyer RP
    Muscle Nerve; 2005 Nov; 32(5):656-63. PubMed ID: 16025531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute alterations in murine neuromuscular transmission following exposure to a nonparalytic dose of dithiobiuret.
    Spitsbergen JM; Atchison WD
    Toxicol Appl Pharmacol; 1990 Jan; 102(1):68-79. PubMed ID: 2153319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic vesicle pools at diaphragm neuromuscular junctions vary with motoneuron soma, not axon terminal, inactivity.
    Mantilla CB; Rowley KL; Zhan WZ; Fahim MA; Sieck GC
    Neuroscience; 2007 Apr; 146(1):178-89. PubMed ID: 17346898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovalbumin-induced sensitization affects non-quantal acetylcholine release from motor nerve terminals and alters contractility of skeletal muscles in mice.
    Teplov AY; Grishin SN; Mukhamedyarov MA; Ziganshin AU; Zefirov AL; Palotás A
    Exp Physiol; 2009 Feb; 94(2):264-8. PubMed ID: 19060115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of perisynaptic Schwann cells in development of neuromuscular junctions in the frog (Xenopus laevis).
    Herrera AA; Qiang H; Ko CP
    J Neurobiol; 2000 Dec; 45(4):237-54. PubMed ID: 11077428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of glial cells in the formation and maintenance of the neuromuscular junction.
    Feng Z; Ko CP
    Ann N Y Acad Sci; 2008; 1132():19-28. PubMed ID: 18567850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age dependence of dithiobiuret neurotoxicity in male and female rats.
    Atchison WD; Dickins J; Peterson RE
    Neurotoxicology; 1982 Dec; 3(4):233-41. PubMed ID: 6820684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential neural regulation of a neuromuscular junction-associated antigen in muscle fibers and Schwann cells.
    Astrow SH; Son YJ; Thompson WJ
    J Neurobiol; 1994 Aug; 25(8):937-52. PubMed ID: 7525869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to D-tubocurarine of the rat diaphragm as compared to a limb muscle: influence of quantal transmitter release and nicotinic acetylcholine receptors.
    Nguyen-Huu T; Molgó J; Servent D; Duvaldestin P
    Anesthesiology; 2009 May; 110(5):1011-5. PubMed ID: 19352164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.